Remdesivir – Outpatients

RECOMMENDATION: We recommend against the routine use of Remdesivir in all out-patients with 1 risk factor with non severe COVID-19 illness. There is no mortality benefit and it does not reduce progression to intensive care. It may reduce hospitalization or medically attended visits.

DATE OF RECOMMENDATION:  04th May 2022